Onium Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 20-12-2024
- Paid Up Capital ₹ 0.10 M
as on 20-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 191.25%
(FY 2022)
- Profit -87157.60%
(FY 2022)
- Ebitda 32.68%
(FY 2022)
- Net Worth
- Total Assets 56.74%
(FY 2022)
About Onium Life Sciences
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ramesh Patnam, Purushottam Dewang, and Saravanan Vadivelu serve as directors at the Company.
- CIN/LLPIN
U73100KA2019PTC120024
- Company No.
120024
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2019
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Onium Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saravanan Vadivelu  | Director | 04-Jan-2019 | Current |
| Ramesh Patnam | Director | 04-Jan-2019 | Current |
| Purushottam Dewang | Director | 04-Jan-2019 | Current |
Financial Performance of Onium Life Sciences.
Onium Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 191.25% increase. The company also saw a substantial fall in profitability, with a 87157.6% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onium Life Sciences?
Unlock access to Onium Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Nutrig1 Research And Development Private LimitedActive 5 years 1 monthPurushottam Dewang is a mutual person
Cropg1 Agro Research & Development Private LimitedActive 7 years 1 monthPurushottam Dewang is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Onium Life Sciences?
Unlock and access historical data on people associated with Onium Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onium Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onium Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
